The primary aim of this study is to assess if the mobility dose that patients receive in the surgical intensive care unit (SICU) predicts adverse discharge disposition (primary endpoint), and muscle wasting diagnosed by bedside ultrasound (secondary endpoint).
Our research group aims to better understand how patients on the SICU are mobilized and the impact it has on adverse discharge disposition and functional outcome after hospital discharge. We have previously developed and validated the Surgical Intensive Care Unit Optimal Mobilization Score (SOMS), an algorithm to guide and facilitate early mobilization to advance mobility of SICU patients (NCT01363102). In addition, we have established the use of bedside ultrasound technology to quantify cross sectional area of the rectus femoris muscle, which allows an objective, user-independent quantification of muscle wasting (NCT02270502). In this study we measure the dose of mobility, defined as a function of both the mobility provided by nursing and physical therapists (e.g., sitting at the edge of the bed, ambulating) as well as its duration. We will build on an existing mobility intensity quantification tool (NCT01674608) and add a domain that quantifies its duration in order to obtain a broad picture of the mobilization of patients on the SICU. The mobility dose is expressed by the mobility quantification score that has been developed by our team. We will then test the hypotheses that mobilization dose in the ICU predicts discharge disposition, defined as discharge to facilities providing long-term care assistance for daily activities, including nursing homes and skilled nursing facilities, hospice at the patient's home, hospice in a health care facility; or in-hospital mortality. Further we will evaluate the association between mobility dose and cross sectional area of the rectus femoris muscle measured by bedside ultrasound as a potential reflection of ICU-acquired muscle weakness (exploratory outcome). Mobilization Quantification score: MQS (Detailed table linked in reference section) This score integrates the highest rated activities within each mobility session - from physical therapy and nursing. By multiplying the scale it gets greater and allows a better interpretation of mobility intensity. It adds value of mobility dose across sessions considering the entire spectrum of active participation of the patient over the day. Some specifics: * If patient achieves a level in between predefined MQS levels we score the closest lower level * We collect mobility data for the night time by interviewing the day nurses and asking them about the patients' mobilization also during night time * We round up the duration of each mobility session: Passive range of motion (PRM) conducted 4 times during the day counts as: 1\*4=4 (corresponding to 4 units/hours) * For each session, we calculate the highest mobility level for the duration of the mobility session: e.g. Patient is standing for 5 minutes before s/he walks with 2 assists for 10 minutes: 3\*7=21 (adding up the duration of various activities within a session and multiplying it by the highest achieved mobility level). Sitting passively in the chair is an exception (see below). Sitting: * Sitting in the chair counts as a separate session. Per sitting session a maximum of 2 hours are counted. For example: if a patient was sitting for a duration of either 2, 4 or 5 hours, we would always count: 2\*4=8 * For patients stepping/shuffling/walking to the chair we use level 5 every time the patient is doing it. E.g. patient is shuffling to the chair, sitting for 2 hours and then walking back: 5\*1+2\*4+5\*1 =28 * Distinct sitting sessions are defined by the patient being back in bed in between the sessions of sitting in the chair. E.g. the patient gets actively to chair by stand-step/shuffle, sits in chair for 6 hours, during sitting session patient gets up twice and afterwards gets back to bed by stand-step/shuffle: 5\*1(to chair)+2\*4(sitting)+5\*1(back to bed)+5\*2(standing up 2x in between)=28
Study Type
OBSERVATIONAL
Enrollment
150
Massachusetts General Hospital
Boston, Massachusetts, United States
RECRUITINGKlinikum Rechts der Isar
Munich, Bavaria, Germany
RECRUITINGUniversità degli Studi di Brescia
Brescia, Lombardy, Italy
RECRUITINGAdverse Hospital Discharge Disposition
Adverse hospital discharge is defined as discharge to facilities providing long-term care assistance for daily activities, including nursing homes and skilled nursing facilities, hospice at the patient's home, hospice in a health care facility, or in-hospital mortality.
Time frame: Patient will be followed until hospital discharge, an expected 3 to 30 days
Rectus Femoris Muscle Cross Sectional Area
Rectus femoris cross sectional area will be measured by bedside ultrasound
Time frame: Rectus femoris cross sectional area will be measured twice, at enrollment and day of ICU discharge, an expected 3 to 30 days.
Mobility Dose as measured by the Mobilization Quantification Score (MQS)
Mobilization Quantification Score (MQS) is a composition of the validated ICU mobility score, a 0 to 10 value scale that measures the mobility milestones in critically ill patients, multiplied by a for each level previously defined time unit (5 or 30 minutes correspond to one unit).
Time frame: Patients will be followed until SICU discharge, an expected 3 to 30 days.
Abbreviated Functional independence measure (FIM) score at Surgical Intensive Care Unit (SICU) discharge and hospital discharge
Abbreviated FIM score obtained by physical therapy (PT) within 48 hours of discharge, and by research assistant on the day of discharge if the subject was not seen by PT in the indicated time period.
Time frame: Patients will be followed until hospital discharge an expected 3 to 40 days.
SICU length of stay
Number of days from SICU admission to SICU discharge
Time frame: Patients will be followed until SICU discharge, an expected 3 to 30 days.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital length of stay
Number of days from hospital admission to hospital discharge
Time frame: Patients will be followed until hospital discharge an expected 3 to 40 days.
SICU Ventilator-free days
Number of days spent on the SICU that patient is not receiving mechanical ventilation.
Time frame: Patients will be followed until ICU discharge, an expected 3 to 30 days.
SICU Vasopressor-free days
Number of days spent on the SICU that patient is not receiving any vasopressor medications.
Time frame: Patients will be followed until ICU discharge, an expected 3 to 30 days.
SICU Delirium-free days
Days spent on the SICU that patient is Confusion assessment method (CAM)-ICU/Richmond Agitation-Sedation Scale (RASS) negative.
Time frame: Patients will be followed until ICU discharge, an expected 3 to 30 days.
SICU Neuromuscular Blocking drug-free days
Number of days spent on the ICU that patient is not receiving Neuromuscular Blocking Agents
Time frame: Patients will be followed until ICU discharge, an expected 3 to 30 days.
Opioid Use
Opioid dose administered, calculated as morphine equivalent dose.
Time frame: Patients will be followed until ICU discharge, an expected 3 to 30 days.
Corticosteroid Days
Number of day on ICU with corticosteroid administration Number of day on ICU with corticosteroid administration Number of ICU days with corticosteroid administration
Time frame: Patients will be followed until ICU discharge, an expected 3 to 30 days.
Physical Work Capacity
Obtained after hospital discharge, measured by the Duke Activity Status Index (DASI)
Time frame: Measured three months after hospital discharge
3-Month Mortality
Time frame: Evaluated three months after hospital discharge
Falls
Number of Falls during ICU stay
Time frame: Patients will be followed until ICU discharge, an expected 3 to 30 days.
Side effects of mobilization therapy
Number of unfavorable signs and symptoms or unintended deterioration of clinical status associated with mobilization therapy, including, but not limited to, unplanned extubation or dislodgment of drains, arterial catheters, venous devices, or other medical equipment. The relationship of any untoward event to mobilization therapy was assessed by the clinician and reported as unrelated, unlikely, possibly, or definitely related. Adverse events (AE) were also categorized by intensity as mild, moderate, or severe
Time frame: Patients will be followed until ICU discharge, an expected 3 to 30 days.